BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bewersdorf JP, Giri S, Tallman MS, Zeidan AM, Stahl M. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—A systematic review and meta‐analysis. Transfusion 2020;60:2360-9. [DOI: 10.1111/trf.15994] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Gómez-De León A, Demichelis-Gómez R, da Costa-Neto A, Gómez-Almaguer D, Rego EM. Acute myeloid leukemia: challenges for diagnosis and treatment in Latin America. Hematology 2023;28:2158015. [PMID: 36607152 DOI: 10.1080/16078454.2022.2158015] [Reference Citation Analysis]
2 Reschke A, Richards RM, Smith SM, Long AH, Marks LJ, Schultz L, Kamens JL, Aftandilian C, Davis KL, Gruber T, Sakamoto KM. Development of clinical pathways to improve multidisciplinary care of high-risk pediatric oncology patients. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1033993] [Reference Citation Analysis]
3 Wolf J, Thomas I, Stanworth S, Knapper S, Griffin J. Leukocytapheresis in the management of adults with acute myeloid leukaemia: A survey of AML treating centres highlighting variability in practice. Transfus Med 2022. [PMID: 36260030 DOI: 10.1111/tme.12929] [Reference Citation Analysis]
4 Macaron W, Sargsyan Z, Short NJ. Hyperleukocytosis and leukostasis in acute and chronic leukemias. Leukemia & Lymphoma 2022;63:1780-1791. [DOI: 10.1080/10428194.2022.2056178] [Reference Citation Analysis]
5 Kim K, Konopleva M, DiNardo CD, Borthakur G, Loghavi S, Tang G, Daver N, Pemmaraju N, Jabbour E, Rausch CR, Yilmaz M, Sasaki K, Short NJ, Jain N, Brandt M, Pierce S, Garcia-Manero G, Ravandi F, Kantarjian H, Kadia TM. Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials. Am J Hematol 2022;97:885-94. [PMID: 35413152 DOI: 10.1002/ajh.26572] [Reference Citation Analysis]
6 Jones SR, Rahrig A, Saraf AJ. Leukapheresis in Pediatric Acute Leukemia with Hyperleukocytosis: A Single-Center Experience. Children 2022;9:503. [DOI: 10.3390/children9040503] [Reference Citation Analysis]
7 Rinaldi I, Sutandyo N, Winston K. Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis. Hematology 2022;27:141-9. [DOI: 10.1080/16078454.2021.2024939] [Reference Citation Analysis]
8 Siegal T, Benouaich-Amiel A, Bairey O. Neurologic complications of acute myeloid leukemia. Diagnostic approach and therapeutic modalities. Blood Rev 2021;:100910. [PMID: 34836656 DOI: 10.1016/j.blre.2021.100910] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Bewersdorf JP, Allen C, Mirza AS, Grimshaw AA, Giri S, Podoltsev NA, Gowda L, Cho C, Tallman MS, Zeidan AM, Stahl M. Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation-A Systematic Review and Meta-Analysis. Transplant Cell Ther 2021:S2666-6367(21)01227-6. [PMID: 34551341 DOI: 10.1016/j.jtct.2021.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Rinaldi I, Sari RM, Tedhy VU, Winston K. Leukapheresis Does Not Improve Early Survival Outcome of Acute Myeloid Leukemia with Leukostasis Patients - A Dual-Center Retrospective Cohort Study. J Blood Med 2021;12:623-33. [PMID: 34290537 DOI: 10.2147/JBM.S312140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Pons M, Zeyn Y, Zahn S, Mahendrarajah N, Page BDG, Gunning PT, Moriggl R, Brenner W, Butter F, Krämer OH. Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition. Cancers (Basel) 2021;13:3464. [PMID: 34298678 DOI: 10.3390/cancers13143464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Bewersdorf JP, Sheth AH, Vetsa S, Grimshaw A, Giri S, Podoltsev NA, Gowda L, Tamari R, Tallman MS, Rampal RK, Zeidan AM, Stahl M. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis-A Systematic Review and Meta-Analysis. Transplant Cell Ther 2021:S2666-6367(21)00935-0. [PMID: 34052505 DOI: 10.1016/j.jtct.2021.05.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lee H, Park S, Yoon JH, Cho BS, Kim HJ, Lee S, Kim DW, Chung NG, Cho B, Kim KB, Yoo J, Jekarl DW, Chae H, Lim J, Kim M, Oh EJ, Kim Y. The factors influencing clinical outcomes after leukapheresis in acute leukaemia. Sci Rep 2021;11:6426. [PMID: 33742034 DOI: 10.1038/s41598-021-85918-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhao J, Bewersdorf JP, Jaszczur S, Kowalski A, Perreault S, Schiffer M, Gore S, Podoltsev N, Prebet T, Shallis R, Zeidan AM. High dose cyclophosphamide for cytoreduction in patients with acute myeloid leukemia with hyperleukocytosis or leukostasis. Leuk Lymphoma 2021;62:1195-202. [PMID: 33325761 DOI: 10.1080/10428194.2020.1856835] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bewersdorf JP, Zeidan AM. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments? Cells 2020;9:E2310. [PMID: 33080779 DOI: 10.3390/cells9102310] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
16 Dzulko M, Pons M, Henke A, Schneider G, Krämer OH. The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation. Biochim Biophys Acta Rev Cancer 2020;1874:188453. [PMID: 33068647 DOI: 10.1016/j.bbcan.2020.188453] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kunitomo Y, Lee S, Avery CC, Valda Toro PL, Cohen AJ, Ehtashimi-afshar S, Kahn PA, Siddon A, Boddu P, Datta R, Dela Cruz CS, Gautam S. Indolent Presentations of Leukemic Lung Disease in Acute Myeloid Leukemia.. [DOI: 10.1101/2020.10.12.20211276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]